Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Janus

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Drugs|July 26, 2014
New therapies for hepatitis C: considerations in patients with renal impairmentSarah Zimner-Rapuch, Nicolas Janus, Gilbert Deray, et al.
Bulletin Du Cancer|December 3, 2011
[Management of chemotherapy in hemodialysis patients]Nicolas Janus, Vincent Launay-Vacher, Gilbert Deray, et al.
Radiology|February 27, 2009
Renal safety of gadolinium-based contrast media in patients with chronic renal insufficiencyElena Ledneva, Svetlana Karie, Vincent Launay-Vacher, et al.
Cancers|April 15, 2020
Are Patients with Active Cancer and Those with History of Cancer Carrying the Same Risks of Recurrent VTE and Bleeding While on Anticoagulants?Corinne Frere, Benjamin Crichi, Manon Lejeune, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 11, 2007
Vaccination and chronic kidney diseaseNicolas Janus, Launay-Vincent Vacher, Svetlana Karie, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 27, 2006
Pharmacokinetics and dosage adjustment of oseltamivir and zanamivir in patients with renal failureSvetlana Karie, Vincent Launay-Vacher, Nicolas Janus, et al.
Clinical Drug Investigation|December 12, 2012
Pulmonary hypertension: use of oral drugs in patients with renal insufficiencySarah Zimner-Rapuch, Sabine Amet, Nicolas Janus, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 7, 2021
Incidence, risk factors, and management of bleeding in patients receiving anticoagulants for the treatment of cancer-associated thrombosisCorinne Frere, Carme Font, Francis Esposito, et al.
Nephrologie & Therapeutique|November 22, 2021
[Renal toxicity of anticancer drugs]Blandine Aloy, Nicolas Janus, Corine Isnard-Bagnis, et al.
Drug Safety|February 2, 2013
Malaria prophylaxis in patients with renal impairment: a reviewSabine Amet, Sarah Zimner-Rapuch, Vincent Launay-Vacher, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Drugs|July 26, 2014
New therapies for hepatitis C: considerations in patients with renal impairmentSarah Zimner-Rapuch, Nicolas Janus, Gilbert Deray, et al.
Bulletin Du Cancer|December 3, 2011
[Management of chemotherapy in hemodialysis patients]Nicolas Janus, Vincent Launay-Vacher, Gilbert Deray, et al.
Radiology|February 27, 2009
Renal safety of gadolinium-based contrast media in patients with chronic renal insufficiencyElena Ledneva, Svetlana Karie, Vincent Launay-Vacher, et al.
Cancers|April 15, 2020
Are Patients with Active Cancer and Those with History of Cancer Carrying the Same Risks of Recurrent VTE and Bleeding While on Anticoagulants?Corinne Frere, Benjamin Crichi, Manon Lejeune, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 11, 2007
Vaccination and chronic kidney diseaseNicolas Janus, Launay-Vincent Vacher, Svetlana Karie, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 27, 2006
Pharmacokinetics and dosage adjustment of oseltamivir and zanamivir in patients with renal failureSvetlana Karie, Vincent Launay-Vacher, Nicolas Janus, et al.
Clinical Drug Investigation|December 12, 2012
Pulmonary hypertension: use of oral drugs in patients with renal insufficiencySarah Zimner-Rapuch, Sabine Amet, Nicolas Janus, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 7, 2021
Incidence, risk factors, and management of bleeding in patients receiving anticoagulants for the treatment of cancer-associated thrombosisCorinne Frere, Carme Font, Francis Esposito, et al.
Nephrologie & Therapeutique|November 22, 2021
[Renal toxicity of anticancer drugs]Blandine Aloy, Nicolas Janus, Corine Isnard-Bagnis, et al.
Drug Safety|February 2, 2013
Malaria prophylaxis in patients with renal impairment: a reviewSabine Amet, Sarah Zimner-Rapuch, Vincent Launay-Vacher, et al.
Pageof 5